Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07133412 · ClinicalTrials.gov registry record · NA
An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph
A NA study, sponsored by Joseph D. Tobias.
- Not yet
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07133412 is a NA study that has not yet begun recruiting, run by Joseph D. Tobias. The registered enrollment target is 100 participants.
The verdict
NCT07133412, a NA study, has not yet begun recruiting, sponsored by Joseph D. Tobias.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal of this study is to use electromyography-based train-of-four monitoring (TetraGraph™ Neuromuscular Transmission Monitor) as a means of evaluating differences in neuromuscular transmission between infants ≤ 3 months of age and adolescent and older patients (≥ 12 years of age).
Interventions
- DEVICE TetraGraph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-07 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07133412
The ClinicalTrials.gov registry entry for NCT07133412 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joseph D. Tobias, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TetraGraph is the first listed.
NCT07133412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07133412 about?
NCT07133412 is a clinical study titled "An Evaluation of the Neuromuscular Junction in Neonates Using the TetraGraph". The goal of this study is to use electromyography-based train-of-four monitoring (TetraGraph™ Neuromuscular Transmission Monitor) as a means of evaluating differences in neuromuscular transmission between infants ≤ 3 months of age and adolescent and older patients (≥ 12 years of age).
What is the current status of trial NCT07133412?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-07. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07133412?
The interventions under investigation include: TetraGraph (DEVICE).
Who is sponsoring clinical trial NCT07133412?
This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.